![PDF] Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics | Semantic Scholar PDF] Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/64d620321dfe4fcc85537c0e0a6f9260a019b8fa/2-Figure1-1.png)
PDF] Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics | Semantic Scholar
![Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs) - ScienceDirect Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666572721000535-gr1.jpg)
Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs) - ScienceDirect
![Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | American Society of Nephrology Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/14/2/278/F2.large.jpg)
Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | American Society of Nephrology
![Mechanism of action of warfarin, dabigatran, rivaroxaban, and apixaban... | Download Scientific Diagram Mechanism of action of warfarin, dabigatran, rivaroxaban, and apixaban... | Download Scientific Diagram](https://www.researchgate.net/profile/Irene-Predazzi/publication/236090583/figure/fig1/AS:601591971315727@1520442111483/Mechanism-of-action-of-warfarin-dabigatran-rivaroxaban-and-apixaban-in-relation-to-the_Q640.jpg)
Mechanism of action of warfarin, dabigatran, rivaroxaban, and apixaban... | Download Scientific Diagram
![Rivaroxaban for the treatment and prevention of thromboembolic disease - Antoniou - 2015 - Journal of Pharmacy and Pharmacology - Wiley Online Library Rivaroxaban for the treatment and prevention of thromboembolic disease - Antoniou - 2015 - Journal of Pharmacy and Pharmacology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/72a15a22-fb0e-48f4-b7ed-629d1716083c/jphp12387-fig-0001-m.jpg)
Rivaroxaban for the treatment and prevention of thromboembolic disease - Antoniou - 2015 - Journal of Pharmacy and Pharmacology - Wiley Online Library
![Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition - Thrombosis Research Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition - Thrombosis Research](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/72b4d946-d2fd-4adb-9abc-044b8aebf351/gr1.jpg)
Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition - Thrombosis Research
![The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants - ScienceDirect The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0049384810004810-gr1.jpg)
The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants - ScienceDirect
![The Direct Oral Anticoagulants Apixaban, Rivaroxaban, and Edoxaban | American Society for Clinical Laboratory Science The Direct Oral Anticoagulants Apixaban, Rivaroxaban, and Edoxaban | American Society for Clinical Laboratory Science](http://clsjournal.ascls.org/content/ascls/30/1/2/F1.large.jpg)
The Direct Oral Anticoagulants Apixaban, Rivaroxaban, and Edoxaban | American Society for Clinical Laboratory Science
![Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring | Thrombosis Journal | Full Text Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring | Thrombosis Journal | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1477-9560-11-10/MediaObjects/12959_2013_Article_185_Fig1_HTML.jpg)
Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring | Thrombosis Journal | Full Text
![Perioperative Management of New Anticoagulants: Novel Drugs and Concepts - Anesthesia Patient Safety Foundation Perioperative Management of New Anticoagulants: Novel Drugs and Concepts - Anesthesia Patient Safety Foundation](https://www.apsf.org/wp-content/uploads/newsletters/2017/Oct/images/NOAC_FIG2.png)